MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Pain"

  • 2022 International Congress

    Cannabinoids for painful dystonia in corticobasal syndrome: a report of three patients

    G. Rizzo, P. Avoni, V. Donadio, R. Liguori (Bologna, Italy)

    Objective: We aimed to assess the efficacy of cannabinoids in painful dystonia of corticobasal syndrome (CBS) patients Background: The clinical phenotype of CBS includes limb…
  • 2022 International Congress

    Deep brain stimulation increases descending inhibitory control in a patient with Parkinson´s disease and pain

    V. Mylius, J. Baars, G. Kägi, M. Krüger, D. de Andrade, F. Brugger (Valens, Switzerland)

    Objective: We present the first observation of deep brain stimulation (DBS) effects on spinal nociception as assessed by the nociceptive flection reflex (NFR) during DBS…
  • 2022 International Congress

    Painful arm spasms after remote electrical injury: focal epilepsy begets causalgia-dystonia?

    J. Cohen, J. Wilkinson (Philadelphia, USA)

    Objective: We describe a case of episodic, painful arm spasms with involuntary tremulous movements, after remote electrocution injury. Background: A variety of movement disorders have…
  • 2022 International Congress

    Non-motor symptoms burden in motor-fluctuating patients with Parkinson’s disease may be alleviated by safinamide: the VALE-SAFI study

    C. Liguori, C. de Masi, M. Spanetta, M. Fernandes, R. Cerroni, E. Garasto, M. Pierantozzi, N. Mercuri, A. Stefani (Rome, Italy)

    Objective: The present study aimed to explore the effect of safinamide treatment on NMS and quality of life in motor-fluctuating PD patients. Background: Parkinson’s disease…
  • MDS Virtual Congress 2021

    Central pain in Parkinson’s disease

    M. Elfekih, I. Bedoui, B. Douma, M. Mansour, H. Derbali, A. Riahi, M. Messelmani, J. Zaouali, R. Mrissa (Nabeul, Tunisia)

    Objective: The objective of our study is to assess the prevalence of central pain in patients with parkinson’s diseaseThe objective of our study is to…
  • MDS Virtual Congress 2021

    Effects of safinamide adjunct therapy on non-motor symptoms in patients with Parkinson’s disease: a post-hoc analysis of the Japanese Phase 2/3 study

    N. Hattori, Y. Tsuboi, Y. Kogo, M. Koebisu, T. Ishida, I. Suzuki, M. Nomoto (Tokyo, Japan)

    Objective: To evaluate the efficacy of safinamide for mood and pain by a post-hoc analysis of the Japanese phase 2/3 double-blind study (JapicCTI-153056) in patients…
  • MDS Virtual Congress 2021

    Safinamide Improves Pain in Parkinson´s Disease. Results from the SAFINONMOTOR Study.

    R. Yáñez, C. Labandeira, M. Cimas Hernando, I. Cabo, J. Paz González, M. Alonso Losada, M. González Palmás, C. Martínez, D. Santos García (Ourense, Spain)

    Objective: Our aim was to analyze the effectiveness of safinamide on pain in Parkinson´s disease (PD) patients from the SAFINONMOTOR (an open-label study of the…
  • MDS Virtual Congress 2021

    The impact of fatigue and pain on functional mobility, fear of falling, and falls in Individuals with Parkinson’s disease

    N. Alissa, H. Khalil, A. Al-Sharman, I. E'Leimat, M. Al-Qawasmeh, K. El-Salem (Baltimore, USA)

    Objective: This is a cross-sectional pilot study aiming to examine: (1) the relationship of fatigue and pain with functional mobility, fear of falling (FOF), and falls in individuals with Parkinson's disease (PD), (2) differences in fatigue and pain between PD fallers and non-fallers, and (3) distinguishing…
  • MDS Virtual Congress 2021

    Back pain in Parkinson’s disease: an underestimated problem

    B. Douma, I. Bedoui, M. Elfekih, H. Derbali, A. Riahi, M. Messelmani, M. Mansour, J. Zaouali, R. Mrissa (Sousse, Tunisia)

    Objective: Estimate the importance of back pain (BP) in Parkinson's disease (PD) and its impact on quality of life. Background: Parkinson's disease (PD) is a…
  • MDS Virtual Congress 2021

    Relationship between low back pain-related disability and motor performance in people with Parkinson disease

    R. Duncan, K. Rawson, T. Baker, J. Cavanaugh, C. Colon-Semenza, T. Deangelis, D. Fulford, M. Lavalley, T. Nordahl, M. Saint-Hillaire, C. Thomas, J. Zajac, T. Ellis, G. Earhart (Saint Louis, USA)

    Objective: To determine the relationship between low back pain (LBP)-related disability and physical performance in people with Parkinson disease (PD). Background: Low back pain is…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 19
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley